Tue, March 12, 2019
Mon, March 11, 2019
Fri, March 8, 2019
Thu, March 7, 2019
Wed, March 6, 2019
Tue, March 5, 2019
Mon, March 4, 2019
Fri, March 1, 2019
Thu, February 28, 2019
Wed, February 27, 2019
Tue, February 26, 2019
Mon, February 25, 2019
Fri, February 22, 2019
Thu, February 21, 2019
Wed, February 20, 2019
Tue, February 19, 2019
Fri, February 15, 2019
Thu, February 14, 2019
Wed, February 13, 2019
Tue, February 12, 2019
Mon, February 11, 2019
Fri, February 8, 2019

Matthew Mishan Maintained (AVNS) at Buy with Decreased Target to $65 on, Feb 27th, 2019


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ith-decreased-target-to-65-on-feb-27th-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI


Matthew Mishan of Keybanc, Maintained "Avanos Medical, Inc." (AVNS) at Buy with Decreased Target from $67 to $65 on, Feb 27th, 2019.

Matthew has made no other calls on AVNS in the last 4 months.



There is 1 other peer that has a rating on AVNS. Out of the 1 peers that are also analyzing AVNS, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Kristen Stewart of "Barclays" Downgraded from Hold to Sell and Decreased Target to $36 on, Friday, January 4th, 2019

Publication Contributing Sources